Calif. city plans to provide transgender surgeries

SAN FRANCISCO (AP) — San Francisco is preparing to become the first U.S. city to provide and cover the cost of sex reassignment surgeries for uninsured transgender residents.

The city’s Health Commission voted Tuesday to create a comprehensive program for treating transgender people experiencing mental distress because of the mismatch between their bodies and their gender identities. San Francisco already provides transgender residents with hormones, counseling and routine health services, but has stopped short of offering surgical interventions, Public Health Director Barbara Garcia said Thursday after the vote was announced.

The idea for a new program that included surgeries came out of conversations between public health officials and transgender rights advocates who wanted mastectomies, genital reconstructions and other surgeries that are recommended for some transgender people covered under San Francisco’s 5-year-old universal health care plan.

At the urging of the San Francisco Board of Supervisors and the San Francisco-based Transgender Law Center, the commission agreed this week to drop sex reassignment surgery from the list of procedures specifically excluded from the Healthy San Francisco plan.

But Garcia described the move as “a symbolic process” for now because the city currently does not have the expertise, capacity or protocols in place to provide the surgeries through its clinics and public hospital.

“The community felt the exclusion on Healthy San Francisco was discriminatory and we wanted to change that as the first step,” she said.

Instead of expanding the existing plan, the Health Commission approved the establishment of a separate program that covers all aspects of transgender health, including gender transition. Garcia hopes to have it running by late next year, but said her department first needs to study how many people it would serve, how much it would cost, who would perform the surgeries and where they would be performed.

“Sex reassignment surgery is not the end all. It’s one service that some transgender people want and some don’t,” she said. “We can probably manage this over the next three years without much of a budget increase because we already have these (other) services covered.”

San Francisco in 2001 became the first city in the country to cover sex reassignment surgeries for government employees. Last year, Portland, Ore. did the same. The number of major U.S. companies covering the cost of gender reassignment surgery for transgender workers also doubled last year, reflecting a decades-long push by transgender activists to get insurance companies to treat such surgeries as medically necessary instead of elective procedures.

Kathryn Steuerman, a member of a transgender health advocacy group in San Francisco, said the city’s latest move would help residents avoid going into debt to finance operations related to gender transition, as she did.

“I am filled with hope and gratitude that we are achieving this level of support for the well-being of the transgender community,” Steuerman said.

Health News Headlines – Yahoo! News

Read More..

Calif. city plans to provide transgender surgeries

SAN FRANCISCO (AP) — San Francisco is preparing to become the first U.S. city to provide and cover the cost of sex reassignment surgeries for uninsured transgender residents.

The city’s Health Commission voted Tuesday to create a comprehensive program for treating transgender people experiencing mental distress because of the mismatch between their bodies and their gender identities. San Francisco already provides transgender residents with hormones, counseling and routine health services, but has stopped short of offering surgical interventions, Public Health Director Barbara Garcia said Thursday after the vote was announced.

The idea for a new program that included surgeries came out of conversations between public health officials and transgender rights advocates who wanted mastectomies, genital reconstructions and other surgeries that are recommended for some transgender people covered under San Francisco’s 5-year-old universal health care plan.

At the urging of the San Francisco Board of Supervisors and the San Francisco-based Transgender Law Center, the commission agreed this week to drop sex reassignment surgery from the list of procedures specifically excluded from the Healthy San Francisco plan.

But Garcia described the move as “a symbolic process” for now because the city currently does not have the expertise, capacity or protocols in place to provide the surgeries through its clinics and public hospital.

“The community felt the exclusion on Healthy San Francisco was discriminatory and we wanted to change that as the first step,” she said.

Instead of expanding the existing plan, the Health Commission approved the establishment of a separate program that covers all aspects of transgender health, including gender transition. Garcia hopes to have it running by late next year, but said her department first needs to study how many people it would serve, how much it would cost, who would perform the surgeries and where they would be performed.

“Sex reassignment surgery is not the end all. It’s one service that some transgender people want and some don’t,” she said. “We can probably manage this over the next three years without much of a budget increase because we already have these (other) services covered.”

San Francisco in 2001 became the first city in the country to cover sex reassignment surgeries for government employees. Last year, Portland, Ore. did the same. The number of major U.S. companies covering the cost of gender reassignment surgery for transgender workers also doubled last year, reflecting a decades-long push by transgender activists to get insurance companies to treat such surgeries as medically necessary instead of elective procedures.

Kathryn Steuerman, a member of a transgender health advocacy group in San Francisco, said the city’s latest move would help residents avoid going into debt to finance operations related to gender transition, as she did.

“I am filled with hope and gratitude that we are achieving this level of support for the well-being of the transgender community,” Steuerman said.

Health News Headlines – Yahoo! News

Read More..

Asian stocks sink on US fiscal cliff fears

HONG KONG (AP) — Asian stock markets sank Friday, weighed down by fears over the so-called U.S. “fiscal cliff” that investors see as a big threat to the economic recovery.

Japan‘s Nikkei 225 index fell 0.9 percent to 8,757.39 and Hong Kong‘s Hang Seng shed 0.5 percent to 21,453.49. South Korea‘s Kospi retreated 1 percent to 1,894.85 and Australia‘s S&P ASX 200 dropped 0.5 percent to 4,462.20.

The slump in Asia mirrored the trend in markets worldwide as investors have refocused on challenges to the world economy following U.S. President Barack Obama’s re-election. Many worry that gridlock in Washington will prevent the president and Congress from reaching a deal before the package of tax increases and government spending cuts kicks in on Jan. 1.

Declines were more muted in mainland China, where investors were awaiting a number of economic indicators that would provide the latest update on the slowdown in the world’s second biggest economy.

The Shanghai Composite Index dipped 0.3 percent to 2,065.92, while the Shenzhen Composite Index lost 0.3 percent to 828.78.

The Chinese benchmarks briefly swung into positive territory after a report released just after trading started showed October inflation had eased to 1.7 percent, giving room for more stimulus. But investors stayed cautious as they awaited industrial production, fixed asset investment and retail sales figures later in the day.

“Markets may stabilize and possibly rebound on Chinese data for October, which we expect to show acceleration of output amid muted price pressures,” strategists at Credit Agricole CIB wrote in a research note.

On Wall Street, the Dow closed down nearly 1 percent to 12,811.32, bringing its two-day loss to 434 points. The Standard and Poor’s 500 index fell 1.2 percent to 1,377.51 and the tech-heavy Nasdaq composite slipped 1.4 percent to 2,895.58.

In currencies, the euro weakened to $ 1.2748 from to $ 1.2750 late Thursday. The dollar strengthened to 79.49 Japanese yen from 79.38 yen.

Crude oil for December delivery was up 12 cents to $ 85.22 in electronic trading on the New York Mercantile Exchange. The contract rose 65 cents to close at $ 85.09 on Thursday.

Economy News Headlines – Yahoo! News

Read More..

Myanmar says Obama to visit later this month

YANGON, Myanmar (AP) — President Barack Obama will make a groundbreaking visit later this month to Myanmar, an official said Thursday, following through with his policy of rapprochement to encourage democracy in the Southeast Asian nation.

The Myanmar official speaking from the capital, Naypyitaw, said Thursday that security for a visit on Nov. 18 or 19 had been prepared, but the schedule was not final. He asked not to be named because he was not authorized to give information to the media.

The official said Obama would meet with opposition leader Aung San Suu Kyi as well as government officials including reformist President Thein Sein.

It would be the first-ever visit to Myanmar by an American president. U.S. officials have not yet announced any plans for a visit, which would come less than two weeks after Obama’s election to a second term.

Obama’s administration has sought to encourage the recent democratic progress under Thein Sein by easing sanctions applied against Myanmar’s previous military regime.

Officials in nearby Thailand and Cambodia have already informally announced plans for visits by Obama that same week. Cambodia is hosting a summit meeting of the Association of Southeast Asian Nations, and Thailand is a longtime close U.S. ally.

The visit to Myanmar, also known as Burma, would be the culmination of a dramatic turnaround in relations with Washington as the country has shifted from five decades of ruinous military rule and shaken off the pariah status it had earned through its bloody suppression of democracy.

Obama’s ending of the long-standing U.S. isolation of Myanmar’s generals has played a part in coaxing them into political reforms that have unfolded with surprising speed in the past year. The U.S. has appointed a full ambassador and suspended sanctions to reward Myanmar for political prisoner releases and the election of Nobel laureate Suu Kyi to parliament.

From Myanmar’s point of view, the lifting of sanctions is essential for boosting a lagging economy that was hurt not only by sanctions that curbed exports and foreign investment, but also by what had been a protectionist, centralized approach. Thein Sein’s government has initiated major economic reforms in addition to political ones.

A procession of senior diplomats and world leaders have traveled to Myanmar, stopping both in the remote, opulent capital city, which was built by the former ruling junta, and at Suu Kyi’s dilapidated lakeside villa in the main city of Yangon, where she spent 15 years under house arrest. New Zealand announced Thursday that Prime Minister John Key would visit Myanmar after attending the regional meetings in Cambodia.

The most senior U.S. official to visit was Hillary Rodham Clinton, who last December became the first U.S. secretary of state to travel to Myanmar in 56 years.

The Obama administration regards the political changes in Myanmar as a marquee achievement in its foreign policy, and one that could dilute the influence of China in a country that has a strategic location between South and Southeast Asia, regions of growing economic importance.

But exiled Myanmar activists and human rights groups are likely to criticize an Obama visit as premature, rewarding Thein Sein before his political and economic reforms have truly taken root. The military — still dominant and implicated in rights abuses — has failed to prevent vicious outbreaks of communal violence in the west of the country that have left scores dead.

Asia News Headlines – Yahoo! News

Read More..

Dancing With The Stars Family Rallies On Twitter In Support Of Brooke Burke-Charvet Following Thyroid Cancer Diagnosis

Members of the “Dancing with the Stars” family Tweeted their well-wishes for the show’s co-host, Brooke Burke-Charvet, who revealed on Thursday she has thyroid cancer.

Helio Castroneves, who was recently eliminated from the “All-Stars” season, said he is confident she will overcome the disease.

PLAY IT NOW: Brooke Burke-Charvet’s Sexy Lingerie Shoot!

“Hi @brookeburke, I have sure that you will win this battle. My affection for you,” the Indy driver wrote.

Brooke revealed on Thursday that she will be undergoing thyroid surgery and a thyroidectomy, and Erin Andrews, who competed in Season 10, noted she was praying for the host.

VIEW THE PHOTOS: The Lovely Brooke Burke-Charvet

“Thinking about @DancingABC friend @brookeburke..Prayers and all the best your way Brooke,” Erin wrote.

Also sending her kind words was Sabrina Bryan, who was eliminated last week on the show.

“@brookeburke hey girl!! You’re in my thoughts and prayers! Always here for you during this fight! Stay strong,” Sabrina wrote.

VIEW THE PHOTOS: Dancing With The Stars: All-Stars — Week 6

Season 13 vet Ricki Lake wrote, “@brookeburke sending huge healing love your way.”

Current contender Melissa Rycroft shared her support, Tweeting, “You’re such a strong woman, and I admire your courage. I hope you feel all the love and support behind you…We love you!”

VIEW THE PHOTOS: ‘Dancing’s’ Derek Hough

And some of the professional dancers chimed in too.

Pro Derek Hough (Brooke’s Season 7 partner) Tweeted, “Love you Brookie B. [You're] in my prayers.”

Cheryl Burke Tweeted, “I love u @brookeburke!! Stay strong. Will be praying for u and sending u lots of positive energy!”

– Jolie Lash

Copyright 2012 by NBC Universal, Inc. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Social Media News Headlines – Yahoo! News

Read More..

Taylor Swift reigns over Billboard 200, Meek Mill debuts high

LOS ANGELES (Reuters) – Country-pop star Taylor Swift held onto the top spot on the Billboard 200 album chart on Wednesday as her latest album “Red” kept rapper Meek Mill from the top spot.

“Red,” Swift’s fourth studio album safely took the No. 1 position after selling 344,000 copies according to figures from Nielsen SoundScan.

Last week, “Red” scored the highest first week U.S. sales in a decade after selling 1.2 million copies. The album has outsold One Direction’s “Up All Night” to become the second-biggest album of 2012, behind Adele’s juggernaut record “21,” which has sold more than 4 million copies this year.

Rapper Meek Mill entered the chart at No. 2 with his debut studio album “Dreams & Nightmares,” selling 164,000 copies. The rapper collaborated with fellow Maybach Music artists for his debut, including Trey Songz, Wale, Rick Ross and Mary J. Blige.

Ahead of the holiday season, two festive albums debuted on the chart, with veteran crooner Rod Stewart’s “Merry Christmas Baby” at No. 3 and Trans-Siberian Orchestra’s extended play record “Dreams of Fireflies (On a Christmas Night)” at No. 9.

Country singer Toby Keith landed at No. 6 with his latest album “Hope on the Rocks,” following his appearance and best music video win at the County Music Association (CMA) awards last week.

Country group Little Big Town also saw a boost from their CMA vocal group of the year win as their album “Tornado” climbed the chart to No. 10.

Canadian singer Neil Young and his band Crazy Horse scored their second top ten album this year with “Psychedelic Pill” at No. 8, following their “Americana” album in June.

Over on the Digital Songs chart, Korean rapper Psy held the top spot with his infectious dance-pop single “Gangnam Style,” while Bruno Mars’ “Locked Out of Heaven” remained at No. 2 and Ke$ ha’s “Die Young” was a non-mover at No. 3.

(Reporting by Piya Sinha-Roy, editing by Jill Serjeant)

Celebrity News Headlines – Yahoo! News

Read More..

Statins may be linked to cancer survival

NEW YORK (Reuters Health) – Danish cancer patients taking cholesterol-lowering statin drugs were 15 percent less likely to die, of cancer or any other cause, than patients who were not on the popular medications, in a new study.

The pattern held regardless of a person’s age, cancer type, tumor size or whether it had spread. Only patients who had received chemotherapy showed no apparent benefit from taking statins – the most commonly-prescribed drugs in the world.

Eric Jacobs, a researcher at the American Cancer Society who was not involved in the new work, called the findings “intriguing and exciting” but said they “do not mean that people with cancer should start using statins in the hopes of improving their progress.”

The study, published Wednesday in the New England Journal of Medicine, did not look at whether the statins, with familiar brand names such as Lipitor and Mevacor, can prevent cancer – only at what happens once cancer is diagnosed.

Using multiple registries containing data on cancer, drug use, population characteristics and deaths for the nation of Denmark, the research team analyzed the cancer cases of 18,721 people over age 40 who were diagnosed between 1995 and 2007.

All were taking statins regularly before their cancer was discovered, and the study compared them to 277,204 people who had not regularly taken the drugs before getting cancer treatments.

Overall, the cancer death rate among statin users was 15 percent lower, and so was the rate of death from any cause.

The appearance of a benefit from taking statins was strongest for 13 cancer types in particular, ranging from an 11 percent lower death rate among pancreatic cancer patients to a 36 percent lower rate among cervical cancer patients. For 14 other tumor types, the results were less clear-cut.

The study’s senior author, Dr. Stig Bojesen of the University of Copenhagen compared the difference in mortality to that seen with chemotherapy. “The benefit of receiving chemotherapy versus not receiving chemotherapy is 15 percent to 20 percent, depending on cancer type,” he told Reuters Health. “What we see (in the new study) is comparable to that. That’s really something.”

The fact that a seeming benefit from statins was not seen in people taking chemotherapy, however, doesn’t mean that people should avoid chemotherapy treatment and turn to statins instead, Bojesen stressed.

Rather, he thinks therapeutic use of statins might be considered when no good chemotherapy option is available for a particular cancer type.

And, if his team’s finding is confirmed in a larger study, statins may offer an easy, inexpensive way to reduce cancer deaths in some patients, he added.

Because the drugs are available in generic form, “The daily cost is about 10 cents or something like that. It’s extremely cheap,” Bojesen said.

An estimated one in four Americans over age 45 takes statin drugs, which work in the liver to reduce the amount of “bad” cholesterol in the bloodstream.

Bojesen speculates that the drugs may be robbing cancer cells of an important building block of cell membranes, and thereby slowing tumor growth.

“Our hypothesis is that by reducing cholesterol, you steal cholesterol from the proliferating cancer cells … improving survival,” he said.

But there is cause for skepticism. The people who took less than the recommended dose of a statin had a higher rate of survival than cancer patients who took higher doses. A positive relationship between dose and response is usually seen as evidence, at least, of cause and effect.

“The absence of a dose trend might indicate that just some statin might be enough,” Bojesen said. “But this is just an observational study, so the exact dose and the exact mechanism is something we can’t clarify with this paper.”

In an editorial accompanying the new report, Dr. Neil Caporaso of the National Cancer Institute said the study is also limited because no information on factors such as smoking were available.

So, for instance, the higher likelihood that people taking statins had heart disease and might therefore have also been targeted for smoking cessation treatment, would muddy the connection between being on statins and having lower cancer mortality.

In addition, information on treatment with chemotherapy and radiation were missing for 72 percent of the people taking statins, he noted.

“Because this study was an observational study, the slightly lower cancer death rates among cancer patients who had used statins before their cancer diagnosis could have been caused by factors other than the statin itself,” Jacobs told Reuters Health. “People using statins may have been more likely to use aspirin, which has been linked with improved cancer survival in some recent studies.”

SOURCE: http://bit.ly/TuzoQN New England Journal of Medicine, online November 7, 2012.

Diseases/Conditions News Headlines – Yahoo! News

Read More..

Statins may be linked to cancer survival

NEW YORK (Reuters Health) – Danish cancer patients taking cholesterol-lowering statin drugs were 15 percent less likely to die, of cancer or any other cause, than patients who were not on the popular medications, in a new study.

The pattern held regardless of a person’s age, cancer type, tumor size or whether it had spread. Only patients who had received chemotherapy showed no apparent benefit from taking statins – the most commonly-prescribed drugs in the world.

Eric Jacobs, a researcher at the American Cancer Society who was not involved in the new work, called the findings “intriguing and exciting” but said they “do not mean that people with cancer should start using statins in the hopes of improving their progress.”

The study, published Wednesday in the New England Journal of Medicine, did not look at whether the statins, with familiar brand names such as Lipitor and Mevacor, can prevent cancer – only at what happens once cancer is diagnosed.

Using multiple registries containing data on cancer, drug use, population characteristics and deaths for the nation of Denmark, the research team analyzed the cancer cases of 18,721 people over age 40 who were diagnosed between 1995 and 2007.

All were taking statins regularly before their cancer was discovered, and the study compared them to 277,204 people who had not regularly taken the drugs before getting cancer treatments.

Overall, the cancer death rate among statin users was 15 percent lower, and so was the rate of death from any cause.

The appearance of a benefit from taking statins was strongest for 13 cancer types in particular, ranging from an 11 percent lower death rate among pancreatic cancer patients to a 36 percent lower rate among cervical cancer patients. For 14 other tumor types, the results were less clear-cut.

The study’s senior author, Dr. Stig Bojesen of the University of Copenhagen compared the difference in mortality to that seen with chemotherapy. “The benefit of receiving chemotherapy versus not receiving chemotherapy is 15 percent to 20 percent, depending on cancer type,” he told Reuters Health. “What we see (in the new study) is comparable to that. That’s really something.”

The fact that a seeming benefit from statins was not seen in people taking chemotherapy, however, doesn’t mean that people should avoid chemotherapy treatment and turn to statins instead, Bojesen stressed.

Rather, he thinks therapeutic use of statins might be considered when no good chemotherapy option is available for a particular cancer type.

And, if his team’s finding is confirmed in a larger study, statins may offer an easy, inexpensive way to reduce cancer deaths in some patients, he added.

Because the drugs are available in generic form, “The daily cost is about 10 cents or something like that. It’s extremely cheap,” Bojesen said.

An estimated one in four Americans over age 45 takes statin drugs, which work in the liver to reduce the amount of “bad” cholesterol in the bloodstream.

Bojesen speculates that the drugs may be robbing cancer cells of an important building block of cell membranes, and thereby slowing tumor growth.

“Our hypothesis is that by reducing cholesterol, you steal cholesterol from the proliferating cancer cells … improving survival,” he said.

But there is cause for skepticism. The people who took less than the recommended dose of a statin had a higher rate of survival than cancer patients who took higher doses. A positive relationship between dose and response is usually seen as evidence, at least, of cause and effect.

“The absence of a dose trend might indicate that just some statin might be enough,” Bojesen said. “But this is just an observational study, so the exact dose and the exact mechanism is something we can’t clarify with this paper.”

In an editorial accompanying the new report, Dr. Neil Caporaso of the National Cancer Institute said the study is also limited because no information on factors such as smoking were available.

So, for instance, the higher likelihood that people taking statins had heart disease and might therefore have also been targeted for smoking cessation treatment, would muddy the connection between being on statins and having lower cancer mortality.

In addition, information on treatment with chemotherapy and radiation were missing for 72 percent of the people taking statins, he noted.

“Because this study was an observational study, the slightly lower cancer death rates among cancer patients who had used statins before their cancer diagnosis could have been caused by factors other than the statin itself,” Jacobs told Reuters Health. “People using statins may have been more likely to use aspirin, which has been linked with improved cancer survival in some recent studies.”

SOURCE: http://bit.ly/TuzoQN New England Journal of Medicine, online November 7, 2012.

Diseases/Conditions News Headlines – Yahoo! News

Read More..

China submarines soon to carry nukes, draft US report says

WASHINGTON (Reuters) – China appears to be within two years of deploying submarine-launched nuclear weapons, adding a new leg to its nuclear arsenal that should lead to arms-reduction talks, a draft report by a congressionally mandated U.S. commission says.

China in the meantime remains “the most threatening” power in cyberspace and presents the largest challenge to U.S. supply chain integrity, the U.S.-China Economic and Security Review Commission said in a draft of its 2012 report to the U.S. Congress.

China is alone among the original nuclear weapons states to be expanding its nuclear forces, the report said. The others are the United States, Russia, Britain and France.

Beijing is “on the cusp of attaining a credible nuclear triad of land-based intercontinental ballistic missiles, submarine-launched ballistic missiles, and air-dropped nuclear bombs,” the report says.

China has had a largely symbolic ballistic missile submarine capability for decades but is only now set to establish a “near-continuous at-sea strategic deterrent,” the draft said.

The deployment of such a hard-to-track, submarine-launched leg of China’s nuclear arsenal could have significant consequences in East Asia and beyond. It also could add to tensions between the United States and China, the world’s two biggest economies.

Any Chinese effort to ensure a retaliatory capability against a notional U.S. nuclear strike “would necessarily affect Indian and Russian perceptions about the potency of their own deterrent capabilities vis-à-vis China,” the report said, for instance.

ARMS CONTROL TALKS URGED

China is party to many major international pacts and regimes regarding nuclear weapons and materials. But it remains outside of key arms limitation and control conventions, such as the New Strategic Arms Reduction Treaty signed in April 2010 and the 1987 Intermediate-Range Nuclear Forces Treaty. The United States historically has approached these bilaterally with Russia.

Congress should require the U.S. State Department to spell out current and planned efforts to integrate China into existing and future nuclear arms reduction, limitation, and control discussions and agreements, the draft said.

In addition, Congress should “treat with caution” any proposal to unilaterally, or in the context of a bilateral deal with Russia, reduce operational U.S. nuclear forces without clearer information being made available to the public about China’s nuclear stockpile and force posture, it said.

A spokesman for the Chinese embassy in Washington, Geng Shuang, did not immediately respond to a request for comment.

China is estimated by the Arms Control Association, a private nonpartisan group in Washington, to have a total of 240 nuclear warheads. The United States, by contrast, has some 5,113, including tactical, strategic and nondeployed weapons.

CHINA DEPLOYING NEW CLASS OF SUBS

Beijing already has deployed two of as many as five of a new class of nuclear-powered ballistic missile submarine. The JIN-class boat is due to carry the JL-2 submarine-launched ballistic missile with an estimated range of about 7,400 km (4,600 miles).

The new submarines and the JL-2 missile will give Chinese forces its “first credible sea-based nuclear capability,” the U.S. Defense Department said in its own 2012 annual report to Congress on military and security developments involving China.

The JL-2 program has faced repeated delays but may reach an initial operating capability within the next two years, according to the Pentagon report, released in May.

The Pentagon declined to comment directly on China’s march toward creating a credible nuclear “triad” involving strategic bombers, intercontinental ballistic missiles and submarine-launched ballistic missiles.

“We monitor carefully China’s military developments and urge China to exhibit greater transparency regarding its capabilities and intentions,” Lieutenant Colonel Monica Matoush, a Defense Department spokeswoman, said by email.

Any assessment of China’s ability to have a nuclear triad would be an intelligence matter and likely be classified in nature, she added.

The final version of the report is to be released next Wednesday by the U.S.-China commission, a 12-member bipartisan group set up in 2000 to report to U.S. lawmakers on security implications of U.S.-China trade.

The draft, in its section on cyber-related issues, called on the Congress to develop a sanctions regime to penalize specific companies found to engage in, or otherwise benefit from, industrial espionage.

Congress should define industrial espionage as an illegal subsidy subject to countervailing duties, it added.

Lawmakers also should craft legislation to boost the security of critical supply chains, “particularly in the context of U.S. government and military procurement,” the draft said.

(Editing by Lisa Shumaker)

Economy News Headlines – Yahoo! News

Read More..

Merkel says Germany, Britain must work together on EU

LONDON (Reuters) – Germany and Britain must cooperate to work round their differences on the European Union‘s long-term spending plans, German Chancellor Angela Merkel said on Wednesday.

“Despite differences that we have it is very important for me that the UK and Germany work together,” Merkel said through a translator before a meeting in London with Prime Minister David Cameron to discuss the EU‘s 2014-2020 budget.

“We always have to do something that will stand up to public opinion back home. Not all of the expenditure that has been earmarked has been used with great efficiency … We need to address that,” she said.

EU leaders meet in Brussels on November 22-23 to try to secure a seven-year budget for the 27-nation bloc amid signs of differences of opinion over what action should be taken.

(Reporting by Peter Griffiths; Editing by Andrew Osborn)

Europe News Headlines – Yahoo! News

Read More..